Low vitamin D linked to severe Parkinsons disease, finds study – Medical Dialogues

Related Articles:

• B Vitamins (Folate, B6, B12) Reduce Homocysteine Levels Produced by Carbidopa/Levodopa Therapy September 12, 2017 “The excitement of vitamins, nutrition and metabolism permeated the environment.” Paul D. Boyer “A substance that makes you ill if you don’t eat it.” Albert Szent-Gyorgy Introduction: Claire McLean, an amazing-PT who is vital to my life managing my Parkinson’s, posted a very interesting article about the generation of homocysteine from the metabolism of levodopa to dopamine in the brain.…
• Low Vitamin D Levels Linked to Added Falls, More Sleep Problems, Depression, Study Shows August 13, 2019 Low vitamin D levels are associated with a greater tendency for falls, sleep problems, anxiety, and depression in people with Parkinson’s disease, according to a recent study. The findings, “Relationship between 25‐Hydroxyvitamin D, bone density, and Parkinson’s disease symptoms,” were published in the journal Acta Neurologica Scandinavia. Vitamin D deficiency and low bone mass are frequently observed in people with…
• Making sense of the latest news about Vitamin B-12 and Parkinson's April 5, 2019 A recent study concluded that one of the active forms of Vitamin B-12 offers neuroprotection and significantly prevents neurotoxicity in animal models of Parkinson's which are influenced by a hereditary genetic variation in the LRRK2 gene. What exactly does that mean? Well, I'm not a scientist, and if you are reading this, you probably aren't either...so let's try to break…
• Mayo Clinic Report on Low Vitamin B-12 and Parkinson’s Disease May 6, 2019 Mayo Clinic has published a research commentary that analyzes the relationship between low levels of Vitamin B-12 and Parkinson's Disease. While the paper does not prove causality, it does "propose that vitamin B12 supplementation could be considered as an adjuvant approach to improve cholinergic transmission and, potentially, motor and cognitive function in patients with PD." And it makes a case…
• Lack of Standardized Vitamin D Data Hampers Efforts to Determine Its Role in Parkinson’s, Review Study Says July 24, 2019 Low vitamin D serum levels have been associated with Parkinson’s disease, but the lack of standardized data makes it difficult to determine vitamin D’s exact role in Parkinson’s pathology, according to a recent review article. The study, “Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer’s disease and Parkinson’s disease,” was published…
• Possible Link Found Between Vitamin B12 Levels and Dementia in Parkinson’s March 27, 2020 People who have higher levels of vitamin B12 in their blood when they’re diagnosed with Parkinson’s disease may be less likely to develop dementia, a study suggests. The study, “Higher vitamin B12 level at Parkinson’s disease diagnosis is associated with lower risk of future dementia,” was published in Parkinsonism & Related Disorders. Dementia describes a group of symptoms in which memory…
• Vitamin D May Improve Balance in Younger Parkinson’s Patients, Pilot Study Suggests October 1, 2018 Short-term supplementation of vitamin D in high doses may improve balance in people with Parkinson’s disease younger than 66, according to results of a Phase 2 pilot study. The study, “A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson’s disease: Does age matter?” was published in Plos One. Parkinson’s patients are at a high…
• Vitamin B12 Supplements May Help Slow Parkinson’s Progression, Study Finds March 14, 2018 Low levels of vitamin B12 in patients in the early stages of Parkinson’s disease are linked to faster motor and cognitive decline, suggesting that vitamin supplements may help slow the progression of these symptoms, a study has found. The study, “Vitamin B12 and homocysteine levels predict different outcomes in early Parkinson’s disease,” was published in the journal Movement Disorders. Several previous…
• Top 10 Parkinson’s Stories of 2019 January 2, 2020 Parkinson’s News Today keeps you up-to-date with research into Parkinson’s disease as it emerges. We brought you daily coverage of experiments into the basic biology of Parkinson’s, results of clinical and pre-clinical trials, and key findings from Parkinson’s research around the globe. We look forward to bringing more such news to those with Parkinson’s, their family, friends and caregivers throughout…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Vitamin B12 May Protect Nerve Cells From Alpha-synuclein Clumps, Study Suggests May 30, 2019 Vitamin B12 can prevent the formation of and destroy alpha-synuclein aggregates in the brain, lowering their toxicity and potentially helping to alleviate Parkinson’s disease, according to a study. The study, “Vitamin B12 inhibits α-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity,” was published in the journal Food & Function. When the brain produces an excess of alpha-synuclein, this protein starts to…
• Top 10 Parkinson’s Stories of 2018 January 2, 2019 Parkinson’s News Today provided you with daily coverage of important findings, treatment developments, and clinical trials related to Parkinson’s during 2018. We look forward to bringing more news to Parkinson’s patients, as well as their family members and caregivers, during 2019. Here are the Top 10 most-read articles of 2018, with a brief description of what made them interesting to the Parkinson’s community.  No.…
• Monthly Research Review – November 2020 November 30, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Peripheral neuropathy and Parkinson’s disease October 20, 2020 Today I will address the potential link between Parkinson’s disease and a common neurologic condition called peripheral neuropathy. This topic was submitted via the Suggest a Topic portal. I am grateful for your suggestions so please continue to let us know what you’d like to learn more about! In order to understand what peripheral neuropathy is and what symptoms it…
• Peripheral neuropathy and Parkinson’s disease October 20, 2020 Today I will address the potential link between Parkinson’s disease and a common neurologic condition called peripheral neuropathy. This topic was submitted via the Suggest a Topic portal. I am grateful for your suggestions so please continue to let us know what you’d like to learn more about! In order to understand what peripheral neuropathy is and what symptoms it…
• How your diet could help alleviate anxiety and panic disorders in Parkinson’s November 8, 2017 Our regular guest dietician, Kathrynne Holden, looks at the nutritional deficiencies that can lead to the worsening of non-motor Parkinson’s symptoms – such as anxiety and panic disorders – and provides tips for healthy eating People with Parkinson’s can often experience non-motor symptoms such as anxiety and panic disorders. Anxiety is a condition that causes fear, worrying, and/or nervousness. The…
• Vitamin E and vitamin C intake may lower risk of Parkinsons disease: Study - Medical Dialogues January 11, 2021 Vitamin E and vitamin C intake may lower risk of Parkinsons disease: Study  Medical Dialogues
• Not dead, dormant dopamine neurons?!? January 18, 2020   Every textbook written about the condition will tell you that the classical pathological characteristic of Parkinson’s is the loss of dopamine neurons in the midbrain region of the brain. It is the distinguishing feature that pathologists look for in order to provide a postmortem diagnosis of the condition. But what is meant by the words ‘loss of dopamine neurons’?…
• Active Form of Vitamin B12 Can Prevent Neurodegeneration in Parkinson’s Preclinical Models April 29, 2019 An active form of vitamin B12 can reduce the effects of dopamine loss in Parkinson’s disease caused by genetic mutations in the LRRK2 gene, a study suggests. These finding means that this form of vitamin B12 could be used as the basis for developing new therapies for treating Parkinson’s. The study, “Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric…
• Journey With Parkinson’s: (Part 2) A Different Side of Life November 2, 2020 “Yesterday is but today’s memory, and tomorrow is today’s dream.” Khalil Gibran “Time is free, but it’s priceless. You can’t own it, but you can use it. You can’t keep it, but you can spend it. Once you’ve lost it you can never get it back.” Harvey Mackay Introduction: I am a scientist, trained as a protein chemist with expertise…
• Journey With Parkinson’s: (Part 2) A Different Side of Life November 2, 2020 “Yesterday is but today’s memory, and tomorrow is today’s dream.” Khalil Gibran “Time is free, but it’s priceless. You can’t own it, but you can use it. You can’t keep it, but you can spend it. Once you’ve lost it you can never get it back.” Harvey Mackay Introduction: I am a scientist, trained as a protein chemist with expertise…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…